Cuprina Holdings (Cayman) Limited (CUPR)
NASDAQ: CUPR · Real-Time Price · USD
7.73
-0.22 (-2.77%)
At close: Jul 22, 2025, 4:00 PM
7.46
-0.27 (-3.49%)
After-hours: Jul 22, 2025, 7:59 PM EDT

Company Description

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds.

The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name.

It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste; and products using medical leeches for wound treatment.

The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.

Cuprina Holdings (Cayman) Limited
Cuprina Holdings (Cayman) Limited logo
CountrySingapore
Founded2019
IPO DateApr 10, 2025
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees14
CEOYong Qi Quek

Contact Details

Address:
Blk 1090, Lower Delta Road #06-08
Singapore, 169201
Singapore
Phone65 8512 7275
Websitecuprina.com.sg

Stock Details

Ticker SymbolCUPR
ExchangeNASDAQ
Share ClassClass A Shares
Fiscal YearJanuary - December
Reporting CurrencySGD
IPO Price$4.00
CIK Code0001995704
ISIN NumberKYG2592E1026
SIC Code3842

Key Executives

NamePosition
Yong Qi QuekChief Executive Officer and Director
Carl Marc BaptistaFounder, Chief Technology Officer and Director
Tat Jing ChanChief Financial Officer and Financial Controller
Dr. Naresh Waran GnanasegaranHead of Research & Development

Latest SEC Filings

DateTypeTitle
Jul 21, 20256-KReport of foreign issuer
Jul 1, 20256-KReport of foreign issuer
Jun 30, 20256-KReport of foreign issuer
Jun 4, 20256-KReport of foreign issuer
May 14, 202520-FAnnual and transition report of foreign private issuers
May 8, 20256-KReport of foreign issuer
May 8, 20256-KReport of foreign issuer
May 5, 20256-KReport of foreign issuer
Apr 17, 2025NT 20-FNotification of inability to timely file Form 20-F
Apr 11, 20256-KReport of foreign issuer